Literature DB >> 11777802

Drug points: Ticlopidine associated with acute arthritis.

Habib A Dakik1, Ibrahim Salti, Rachid Haidar, Imad W Uthman.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2002        PMID： 11777802      PMCID： PMC61656          DOI： 10.1136/bmj.324.7328.27

Source DB:  PubMed          Journal:  BMJ        ISSN： 0959-8138


× No keyword cloud information.
  4 in total

1.  Clopidogrel associated with acute arthritis.

Authors:  A Garg; J Radvan; N Hopkinson
Journal:  BMJ       Date:  2000-02-19

Review 2.  Ticlopidine and clopidogrel.

Authors:  M J Quinn; D J Fitzgerald
Journal:  Circulation       Date:  1999-10-12       Impact factor: 29.690

3.  A clinical trial comparing three antithrombotic-drug regimens after coronary-artery stenting. Stent Anticoagulation Restenosis Study Investigators.

Authors:  M B Leon; D S Baim; J J Popma; P C Gordon; D E Cutlip; K K Ho; A Giambartolomei; D J Diver; D M Lasorda; D O Williams; S J Pocock; R E Kuntz
Journal:  N Engl J Med       Date:  1998-12-03       Impact factor: 91.245

4.  A randomized trial comparing ticlopidine hydrochloride with aspirin for the prevention of stroke in high-risk patients. Ticlopidine Aspirin Stroke Study Group.

Authors:  W K Hass; J D Easton; H P Adams; W Pryse-Phillips; B A Molony; S Anderson; B Kamm
Journal:  N Engl J Med       Date:  1989-08-24       Impact factor: 91.245
  4 in total
  5 in total

1.  Careless talk may cost lives in attributing adverse events to ADP receptor antagonists.

Authors:  Michael J Green; Martin Iveson; Robert Crook; Nichola Burrows; Andrew K S Gough
Journal:  BMJ       Date:  2002-04-27

2.  Authors' refute careless talk about ADP receptor antagonists.

Authors:  Imad W Uthman; Habib A Dakik; Ibrahim Salti; Rachid Haidar
Journal:  BMJ       Date:  2002-11-02

3.  Serum sickness-like reaction associated with clopidogrel.

Authors:  Elizabeth J Phillips; Sandra R Knowles; Neil H Shear
Journal:  Br J Clin Pharmacol       Date:  2003-11       Impact factor: 4.335

Review 4.  Drug-induced musculoskeletal disorders.

Authors:  Bernard Bannwarth
Journal:  Drug Saf       Date:  2007       Impact factor: 5.228

5.  Clopidogrel-Induced Recurrent Polyarthritis.

Authors:  Sahil Agrawal; Joseph Harburger; Gary Stallings; Nikhil Agrawal; Jalaj Garg
Journal:  J Investig Med High Impact Case Rep       Date:  2013-08-05
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.